Novosis Putty for Degenerative Disc Disease

This trial tests a new treatment called Novosis Putty for individuals with lumbar degenerative disc disease, a condition where lower back discs deteriorate, causing pain. The study aims to evaluate the safety and effectiveness of Novosis Putty in a specific type of back surgery. Participants will receive either Novosis Putty or the standard treatment to compare outcomes. Those who have experienced lumbar degeneration symptoms and have not found success with other treatments for at least six months may be suitable for this trial. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to the potential availability of a new treatment.

The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

A previous study found Novosis Putty to be safe for patients undergoing spinal fusion surgeries. Patients generally tolerated the treatment well, with no serious side effects directly linked to the putty. Some reported minor side effects, such as mild pain at the application site, but these were manageable and resolved quickly.

Research has shown that Novosis Putty, which contains a protein to aid bone growth, has been tested in several groups. These studies consistently found the treatment safe for similar procedures. The FDA has also given special recognition to the putty, highlighting its potential as a safe option for spine-related treatments.

Unlike standard treatments for degenerative disc disease, which often include pain relievers, physical therapy, or surgery, Novosis Putty presents a novel approach. Researchers are excited about this treatment because it uses a unique biomaterial designed to promote tissue regeneration and repair within the spinal disc itself. This could potentially provide longer-lasting relief and improve spinal function by addressing the underlying cause of disc degeneration, rather than just managing symptoms.

Research has shown that Novosis Putty, which participants in this trial may receive, is designed to strengthen bones while preventing unwanted bone growth elsewhere. It contains a special protein called rhBMP-2, which aids in bone healing, and a ceramic material that supports bone growth. Studies indicate that this combination can help spinal bones fuse together. This is crucial for individuals with degenerative disc disease, where the spine's discs wear down and cause pain. The putty releases the protein slowly, potentially enhancing bone healing over time.¹⁴⁶⁷⁸